Skip to content
  • About
  • Shop
  • News
  • Contact Us
Search
NECA Logo
  • NET Nurse
  • Donate
  • What are NETs?
    • What are Neuroendocrine Cancers?
    • What are Pheos & Paras?
    • NET Symptoms
    • NET Types
    • Causes
    • Treatments
    • Grades
    • Diagnosis
    • Prognosis
    Consider the Grey Area
  • Patients & Carers
    • Patient & Carer Support
    • Patient Resources
    • Optimal Care Pathway
    • NET Nurse
    • Patient Stories
    • Share your Story
    • Australian NET Specialists
    • Clinical Trials
    • Living with NETS
    • Specialist Support Services
    Consider the Grey Area
  • Healthcare Professionals
    • Optimal Care Pathway
    • Professional Learning
    • Patient Referral
    • Clinical Trials
    • NET Symptoms
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order Booklets & Resources
    Consider the Grey Area
  • Get Involved
    • Advocate for Us
    • Share your Story
    • Donate
    • Fundraise
    • Events
    • In Memoriam
    • Corporate Partners
    • Gifts & Wills
    • Volunteer
    Senate MailChimp
  • March4NETs
NET Nurse
Donate

Home » News » NET Patient Chris, from Ballarat, Raises Awareness of Neuroendocrine Cancer

NET Patient Chris, from Ballarat, Raises Awareness of Neuroendocrine Cancer

  • May 5, 2025

NeuroEndocrine Cancer Australia (NECA) is proud to recognise the advocacy efforts of NET patient Chris Geljon, who has taken the time to raise awareness of neuroendocrine cancer in his local community of Ballarat.

Since being diagnosed, Chris has made it his mission to ensure more people understand what NETs are, how they affect Australians, and why earlier diagnosis and better treatment options matter. After meeting with his local MP Chris has now taken part in newspaper and radio interviews on both 3BA Ballarat and ABC Central Victoria.

Chris’s Media Highlights:

  • ‘Men try to be a bit macho’: cancer fighter’s plea to get body changes checked – Ballarat Courier online]
    Read article here

  • Cancer fighters plea to get checked out. Ballarat Courier Newspaper
    Read article here

  • 3BA Radio Interview 30 April 2025
    Listen to interview here

  • ABC Central Victoria Interview 22 April 2025
    Listen to interview here

Through his story, Chris has raised awareness of NETs in his local community and beyond, encouraging others to speak up, ask questions, and seek support.

“Telling my story has been a way to take something difficult and turn it into something positive. If I can help even one person get diagnosed earlier or feel less alone, it’s worth it,” said Chris.

We are so grateful to Chris for using his voice to support the NET community and championing the mission of NeuroEndocrine Cancer Australia.

If you’re a NET patient and feel inspired to share your story, we would love to hear from you. Personal stories are powerful tools for awareness and change.

Please get in touch at info@neuroendocrine.org.au or visit our patient stories page to learn how you can share your story.

Share this post

Recent posts

Raising awareness of neuroendocrine cancer at Peninsula Bays Hospital Wellness Day

February 9, 2026

Australia delivers excellent cancer care, but not equally

February 4, 2026

NECA Contributes to Multidisciplinary Systemic Review

January 28, 2026

AUS-NET Update, January 2026

January 20, 2026
Categories
  • Advocacy
  • Awareness
  • Community Events
  • Education
  • Events
  • Fundraising
  • General
  • In The Media
  • News
  • Research
  • Unicorn Events
PrevPreviousHelp Us Grow: Connect NECA with Corporate Partners to Make a Lasting Impact
NextVHL Awareness Month 2025Next

Related Posts

Raising awareness of neuroendocrine cancer at Peninsula Bays Hospital Wellness Day

Thank you to NET patient Kristen Leknius for hosting a neuroendocrine cancer information table at the February Peninsula Bays Hospital Wellness Day. With around 250

Australia delivers excellent cancer care, but not equally

Meredith Cummins is CEO of NeuroEndocrine Cancer Australia and incoming President of the International Neuroendocrine Cancer Alliance, representing patient advocacy groups worldwide. Every World Cancer

NECA Contributes to Multidisciplinary Systemic Review

NECA was invited to participate and co-author in a multidisciplinary working group to conduct a systematic review and meta-analysis to evaluate the current evidence on

AUS-NET Update, January 2026

The AUS-NET trial commenced in 2022 and is running through to 2027. Across the five Centres of Excellence—The Queen Elizabeth Hospital, Royal North Shore Hospital,

View All

Subscribe to Newsletter

NECA Logo
registered charity badge

What are NETs

  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies
  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies

Patients & Carers

  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library
  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library

Healthcare Professionals

  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials
  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials

Get Involved

  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
All charity donations to NeuroEndocrine Cancer Australia may be tax-deductible in Australia.

Registered Charity CFN 202607
© 2026 NeuroEndocrine Cancer Australia
  • Website by Five Creative
Twitter Facebook Youtube Instagram Linkedin